English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

American Academy Of Neurology

Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'

Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

Press release submission | May 2, 2019

AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy

Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS

Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise

Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers

Amanda Rupp | May 22, 2016

New ALS research announced at annual conference

Amanda Rupp | Apr 21, 2016

ALS Association announces new research fellowships

Trending

Patient Daily | Oct 22, 2025

Chronic Care Policy Alliance backs federal legislation to reform the 340B Drug Pricing Program

Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues

Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'

Patient Daily | Oct 21, 2025

Gulf Coast Breathe Free Physician Assistant on sinus issues: ‘Certain things like dairy seem to increase mucus production’



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily